Your search returned 7 results.

Results
	1.	Continuous infusion factor replacement in haemophilia B during and after cardiac surgery: the better choice?. MedStar authors: Farid, Saira Sewaralthahab, Sarah Smith, Hedy Patricia PMID: 33257355 Year: 2020 Citation: BMJ Case Reports. 13(11), 2020 Nov 30. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Internal Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Farid S, Sewaralthahab S, Smith HP DOI: https://dx.doi.org/10.1136/bcr-2020-235859 Add to cart (remove)
	2.	Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. MedStar authors: Epstein, Stephen E Lipinski, Michael J PMID: 27856497 Year: 2017 Citation: Circulation Research. 120(2):332-340, 2017 Jan 20 Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Anderson AS, Butler J, Cole RT, Epstein SE, Gheorghiade M, Greene SJ, Kim RJ, Ko YA, Lipinski MJ, Margulies KB, Quyyumi AA, Sikora S, Skopicki HA, Tankovich NI, Wilcox JE DOI: https://dx.doi.org/10.1161/CIRCRESAHA.116.309717 Add to cart (remove)
	3.	Continuous cardiac inotropes in patients with end-stage heart failure: an evolving experience. MedStar authors: Groninger, Hunter Groninger, Hunter Malotte, Kasey Malotte, Kasey Saguros, Agafe PMID: 29030210 Year: 2017 Citation: Journal of Pain & Symptom Management. 55(1):159-163, 2018 Jan. Institution: MedStar Union Memorial Hospital MedStar Washington Hospital Center Department: Medicine/Palliative Care Medline publication type: Journal Article Form of publication: Journal Article All authors: Groninger H, Malotte K, Saguros A DOI: https://dx.doi.org/10.1016/j.jpainsymman.2017.09.026 Add to cart (remove)
	4.	A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design. MedStar authors: Lipinski, Michael J PMID: 27297851 Year: 2016 Citation: American Heart Journal. 177:66-73, 2016 Jul Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Alvaro G, Amantea B, Auci E, Auriemma S, Baiocchi M, Bianchi A, Biondi-Zoccai G, Bove T, Bradic N, Buscaglia G, Calabro MG, Cariello C, Corcione A, De Vuono G, Fominskiy E, Frontini M, Galdieri N, Gemma M, Gianni S, Grigoryev E, Guarracino F, Landoni G, Lembo R, Likhvantsev V, Lipinski MJ, Lobreglio R, Lomivorotov VV, Monaco F, Pala G, Paternoster G, Pisano A, Sangalli F, Wang CY, Zangrillo A, Zucchetti MC DOI: https://dx.doi.org/10.1016/j.ahj.2016.03.021 Add to cart (remove)
	5.	Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 25693012 Year: 2015 Citation: New England Journal of Medicine. 372(8):724-34, 2015 Feb 19. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM DOI: http://dx.doi.org/10.1056/NEJMoa1413513 Add to cart (remove)
	6.	Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. MedStar authors: Kumar, Anjali S PMID: 26187751 Citation: Lancet Oncology. 16(8):957-66, 2015 Aug. Institution: MedStar Washington Hospital Center Department: Surgery/Colorectal Surgery Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Avila K, Cataldo PA, Chow OS, Coutsoftides T, Dietz DW, Fichera A, Garcia-Aguilar J, Herzig DO, Hunt SR, Kumar AS, Marcet JE, Oommen S, Patil S, Polite BN, Smith DD, Stamos MJ, Ternent CA, Timing of Rectal Cancer Response to Chemoradiation Consortium, Varma MG DOI: http://dx.doi.org/10.1016/S1470-2045(15)00004-2 Add to cart (remove)
	7.	Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors: Priebat, Dennis A PMID: 28988646 Year: 2017 Citation: Lancet Oncology. 18(11):1493-1501, 2017 Nov Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II DOI: https://dx.doi.org/10.1016/S1470-2045(17)30624-1 Add to cart (remove)

Powered by Koha